|
Volumn 18, Issue 9, 1997, Pages 1371-1381
|
Selection of reperfusion therapy for individual patients with evolving myocardial infarction
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOLYTIC AGENT;
RETEPLASE;
SARUPLASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
ACUTE HEART INFARCTION;
BRAIN HEMORRHAGE;
CORONARY ARTERY DILATATION;
COST BENEFIT ANALYSIS;
DRUG CHOICE;
FIBRINOLYTIC THERAPY;
HEALTH CARE COST;
HEART;
HEART INFARCTION SIZE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE REPERFUSION;
HUMAN;
MEDICAL DECISION MAKING;
MORBIDITY;
MORTALITY;
PREDICTION;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
STROKE;
SURVIVAL TIME;
TIME;
|
EID: 0030765443
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.eurheartj.a015461 Document Type: Review |
Times cited : (28)
|
References (62)
|